Sorafenib: Drug Summary   Name Sorafenib Chemical formula C21H16CIF3N4O3  Chemical structure Administration route Oral Dosage 400 mg b.i.d. Indication 2005: FDA approval for advanced renal cell carcinoma. 2006:  Marketing authorization given by the  European Commission for renal cell carcinoma. 2007: Marketing authorization given by the European Commission for hepatocellular carcinoma; FDA approval for hepatocellular carcinoma.

Table 1: Drug summary about sorafenib.